rivaroxaban

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of venous or pulmonary clots following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: APL Swift Services (Malta) Ltd.

The medicine is used in adults to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), as well as to prevent the recurrence of such clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: APL Swift Services (Malta) Ltd.

The medicine is used in adults to reduce the risk of a subsequent heart attack or death due to cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Bayer AG Bayer Bitterfeld GmbH Bayer HealthCare Manufacturing S.r.l.

It is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It also helps in the treatment of deep vein thrombosis and pulmonary embolism and prevents their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Bayer AG Bayer Bitterfeld GmbH Bayer HealthCare Manufacturing S.r.l.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and lungs. In children and adolescents (over 30 kg), it is also used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Bayer AG Bayer Bitterfeld GmbH Bayer HealthCare Manufacturing S.r.l.

The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Bayer AG Bayer Bitterfeld GmbH Bayer HealthCare Manufacturing S.r.l.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: SOFARIMEX Indústria Química e Farmacêutica, S.A.

This medicine is used in adults to treat deep vein thrombosis (in the legs) and pulmonary embolism, as well as to prevent the recurrence of blood clots in the blood vessels of the legs and lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: SOFARIMEX Indústria Química e Farmacêutica, S.A.

This medicine is used in adults to prevent strokes and other blood clots in the blood vessels in people with an irregular heartbeat (atrial fibrillation). In adults and adolescents (weighing more than 30 kg), it is also used to treat deep vein thrombosis and pulmonary embolism, and to prevent them from recurring.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: SOFARIMEX Indústria Química e Farmacêutica, S.A.

This medicine is used in adults to prevent strokes and other blood clots in the blood vessels in the case of irregular heart rhythm (atrial fibrillation). In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the leg veins and pulmonary vessels.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: SOFARIMEX Indústria Química e Farmacêutica, S.A.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death due to cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Alvogen Malta (Out-Licensing) Ltd./Amol Ltd. Saneca Pharmaceuticals a. s.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Alvogen Malta (Out-Licensing) Ltd./Amol Ltd. Saneca Pharmaceuticals a. s.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Alvogen Malta (Out-Licensing) Ltd./Amol Ltd. Saneca Pharmaceuticals a. s.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd., G.L. Pharma GmbH, Saneca Pharmaceuticals a.s., S.C. Labormed-Pharma S.A.

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation), as well as to treat and prevent deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat clots in the veins or lungs following initial treatment with injectable medications.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd., G.L. Pharma GmbH, Saneca Pharmaceuticals a.s., S.C. Labormed-Pharma S.A.

In adults, it is used to prevent strokes in people with atrial fibrillation and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial treatment with injectable medications.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd., G.L. Pharma GmbH, Saneca Pharmaceuticals a.s., S.C. Labormed-Pharma S.A.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd.

This medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd.

This medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd.

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism (as well as to prevent their recurrence).

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used for the treatment and prevention of clots in the veins or lungs following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs following initial treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular causes (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa, S.A.

The medicine is used in adults to prevent blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa, S.A.

In adults, it is used to prevent strokes and blood clots (e.g., in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa, S.A.

This medicine is used in adults to prevent strokes and blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots following initial treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa, S.A.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (after a diagnosis of acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd.

This medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels in people with atrial fibrillation. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd.

The medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation). It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent them from recurring.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd.

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg and lung veins. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd.

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd.

The medicine is used in adults diagnosed with acute coronary syndrome (e.g., myocardial infarction) or in patients at high risk of blood clots due to coronary artery disease or peripheral artery disease. It aims to reduce the risk of a subsequent heart attack, cardiovascular death, or the occurrence of blood clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Limited

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Limited

In adults, the medicine is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used to treat clots after initial treatment with injectable medications.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Limited

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg or lung veins. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial treatment with injectable medicines.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Limited

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd., Orion Corporation Orion Pharma, Orion Corporation Orion Pharma, Saneca Pharmaceuticals a.s.

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd., Orion Corporation Orion Pharma, Orion Corporation Orion Pharma, Saneca Pharmaceuticals a.s.

This medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd., Orion Corporation Orion Pharma, Orion Corporation Orion Pharma, Saneca Pharmaceuticals a.s.

The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Farmaprojects S.A.U.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism (and to prevent their recurrence).

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Farmaprojects S.A.U.

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Farmaprojects S.A.U.

It is used in adults to treat deep vein thrombosis (in the legs) and pulmonary embolism, as well as to prevent the recurrence of blood clots in the blood vessels of the legs and lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Farmaprojects S.A.U.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Farmaprojects S.A.U.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs following initial treatment with injections.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of thrombosis following initial injectable treatment.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular causes following acute coronary syndrome. It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.